Knee osteoarthritis injection study halted early
NCT ID NCT03706521
First seen Mar 21, 2026 · Last updated May 20, 2026 · Updated 10 times
Summary
This study tested an injection called lorecivivint for people with moderate to severe knee osteoarthritis. The goal was to see if it could improve cartilage health and reduce pain. Only 13 people took part, and the study was stopped early. It was not a cure, but aimed to control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KNEE OSTEOARTHRITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
San Francisco, California, 94158, United States
Conditions
Explore the condition pages connected to this study.